Viracta Therapeutics Funding: $83M Raised, Series D (2019)

Viracta Therapeutics is a Biotech company based in Cardiff. It has raised $83M in total funding. Latest round: Series D.

Viracta Therapeutics funding overview

Viracta Therapeutics is a Biotech company based in Cardiff. Viracta Therapeutics has raised $83M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series D announced in October 2019. The round record for Viracta Therapeutics runs through 2019; nothing later has been disclosed. Investors on record include Taiwania Capital Management.

Viracta Therapeutics at a glance

Total raised
$83M
Latest round
Series D
Latest round date
October 2019
Industry
Biotech
Headquarters
Cardiff
Notable investors
Taiwania Capital Management

Frequently asked about Viracta Therapeutics funding

How much has Viracta Therapeutics raised?
Viracta Therapeutics has raised $83M in total disclosed funding across the rounds on record.
Who has invested in Viracta Therapeutics?
Taiwania Capital Management are named among the investors backing Viracta Therapeutics.
What was the latest Viracta Therapeutics funding round?
The most recent disclosed round is a Series D, announced in October 2019.
Where is Viracta Therapeutics based?
Viracta Therapeutics is based in Cardiff.
What sector does Viracta Therapeutics operate in?
Viracta Therapeutics is tracked under Biotech from Cardiff, with $83M in disclosed funding.
When did Viracta Therapeutics last raise?
The last disclosed Viracta Therapeutics round closed in October 2019 at Series D.

Round data for Viracta Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Cardiff and backer lists below.

Companies related to Viracta Therapeutics (27)

Browse related funding lists (3)

Company funding database · Investor directory · Founder database · Mega-rounds 2026